NCT07065617View on ClinicalTrials.gov

A Study to Test How BI 1819479 is Taken up and Processed by the Body

PHASE1RecruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 4, 2025

Primary Completion Date

April 19, 2026

Study Completion Date

April 19, 2026

Conditions
Healthy
Interventions
DRUG

[14C]BI 1819479

\[14C\]BI 1819479

DRUG

BI 1819479

BI 1819479

DRUG

BI 1819479 (C-14)

BI 1819479 mixed with \[14C\]BI 1819479

Trial Locations (1)

NG11 6JS

RECRUITING

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY